A potentially safe activator of Kv7 potassium channels to treat epilepsy

Aug. 1, 2025

In the search for effective and safe Kv7 activators, a collaboration spanning Belgium, Germany and Italy has identified JNJ-37822681 as a promising lead.

BioWorld Science Neurology/psychiatric

Today's news in brief

BioWorld

BioWorld briefs for July 17, 2026.

AI-generated illustration of a neuron with tau protein aggregation

AAIC 2026: Age of amyloid is being joined by time of tau

BioWorld

The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...

Celia trial: data strong, analysts skeptical

BioWorld

Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...

News in brief

BioWorld Asia

BioWorld Asia briefs for July 14, 2026

Voyager’s gene therapy reduces tau levels in AD models

BioWorld Science

At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...